Cyteir Therapeutics Inc

NASDAQ:CYT   3:59:50 PM EDT
2.02
+0.11 (+5.76%)
Earnings Announcements

Cyteir Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/05/2022 20:39 GMT
Cyteir Therapeutics Inc (CYT) - Cyteir Therapeutics Reports First Quarter 2022 Financial Results and Operational Highlights.
Q1 Loss per Share $0.40.
Q1 Earnings per Share View $-0.39 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.44

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.46

More details on our Analysts Page.